Rapid Micro Biosystems (RPID) Net Income Growth (3y) (2023 - 2026)
Rapid Micro Biosystems (RPID) Net Income Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.85 Bn | 176.55 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 108.55 Bn | 99.33 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 68.56 Bn | 67.10 Bn | 3.61 Bn | 62.29% |
| 5 | Edwards Lifesciences | 48.24 Bn | 44.57 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | 60.12% |
| 7 | GE HealthCare Technologies | 28.15 Bn | 25.87 Bn | 1.98 Bn | 2.38% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.75 Bn | 21.63 Bn | 2.07 Bn | 280.49% |
| 10 | Rapid Micro Biosystems | 89.96 Mn | 80.52 Mn | 371,000.00 | -0.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.92% |
| Dec 31, 2025 | 8.78% |
| Sep 30, 2025 | 11.03% |
| Jun 30, 2025 | 3.27% |
| Mar 31, 2025 | 8.97% |
| Dec 31, 2024 | 12.85% |
| Sep 30, 2024 | 23.19% |
| Jun 30, 2024 | -2.06% |
| Mar 31, 2024 | 15.53% |
| Dec 31, 2023 | 0.49% |
| Sep 30, 2023 | -16.52% |
| Jun 30, 2023 | -14.79% |